AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: A “glycoxidation-centric” point of view
Authors:
- N.C. ChilelliNCN.C. Chilelli
- S. BurlinaSBS. Burlina
- A. LapollaALA. Lapolla
- 1 October 2013
- journal article
- review article
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 23 (10) , 913-919
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Pathogenesis of diabetic neuropathy: bad to the boneAnnals of the New York Academy of Sciences, 2011
- Type 2 diabetes across generations: from pathophysiology to prevention and managementThe Lancet, 2011
- Restriction of Advanced Glycation End Products Improves Insulin Resistance in Human Type 2 DiabetesDiabetes Care, 2011
- Oxidative Stress and Diabetic ComplicationsCirculation Research, 2010
- Metabolic memory: a vascular perspectiveCardiovascular Diabetology, 2010
- Shifting the Disease Management Paradigm From GlucoseDiabetes Care, 2009
- Advanced Glycation End Products in Extracellular Matrix Proteins Contribute to the Failure of Sensory Nerve Regeneration in DiabetesDiabetes, 2009
- The Pathologic Continuum of Diabetic Vascular DiseaseJACC, 2009
- Translating the A1C Assay Into Estimated Average Glucose ValuesDiabetes Care, 2008
- Reduced cell replication and induction of apoptosis by advanced glycation end products in rat Schwann cellsBiochemical and Biophysical Research Communications, 2004